University of Rochester
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Rochester sits in the top decile of US sponsors by registered trial count (#53 of 15,742 sponsors by registered trial count).
University of Rochester: 636 sponsored US clinical trials, 94 recruiting.
University of Rochester sponsors 636 registered US clinical trials on ClinicalTrials.gov, 94 of them currently recruiting, and 448 completed. 54 of these trials are in Phase 3-4 (later-stage) and 147 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cancer, with 7 trials.
Top-decile sponsor footprint
University of Rochester ranks in the top decile of sponsors by registered trial count (#53 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
448 of 506 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
636 total, page 4 of 13
Home Rehabilitation After Acute Pulmonary Embolism
NCT05571189
An Inpatient Advance Care Planning Intervention for Older Patients With Hematologic Malignancies
NCT05433090
VAX-MOM COVID-19: Increasing Maternal COVID-19 Vaccination
NCT05570630
Social-LEAF Life Enhancing Activities for Caregivers
NCT05274074
Topical Ruxolitinib in Chronic Hand Dermatitis
NCT05293717
Network Health Intervention for Adolescents Leaving Acute Psychiatric Care
NCT05340296
Comparison of Ultrasound-guided Intraarticular Hip Injections With and Without Prior Local Anesthesia
NCT05209399
A Patient-Centered Communication Tool (UR-GOAL) Versus Usual Care for Older Patients With Acute Myeloid Leukemia, Their Caregivers, and Their Oncologists
NCT05335369
Evaluating the Use of a Device Called Impulse Oscillometry in Participants With Vocal Cord Disorders or Asthma
NCT05246930
Culture and Well-Being for Latinos
NCT05244733
Latinos Kick Buts: Mobile Engagement and Cessation Support for Latino Smokers
NCT05278481
Study of Ruxolitinib Cream for the Treatment of Discoid Lupus Erythematosus
NCT04908280
Study of Sulphoraphane in Chronic Kidney Disease
NCT05153174
Objective, Passive Assessment of LRRK2 Carriers
NCT05287620
Repeated HBO Therapy in Myeloma Patients Undergoing High-Dose Therapy and Auto-HCT
NCT04862676
Study of a Behavioral Intervention for Older Advanced Cancer Patients and Their Caregivers
NCT05200572
Shared Decision Making in Dialysis
NCT04392440
A Trial of Neurofeedback as an Adjunctive Treatment for Youth in Outpatient Mental Health Settings
NCT04871009
Is Milk Associated with Glycemia in the NICU
NCT05256927
Deaf Weight Wise: Community-engaged Implementation Research to Promote Healthy Lifestyle Change With Deaf ASL Users
NCT05211596
Efficacy Trial of the FMF Connect Mobile Health Intervention
NCT05028517
Text-based Colorectal Cancer Prevention Pilot
NCT05004376
Emergency Department Lung Cancer URMFG Pilot
NCT04979169
A Geriatric Assessment Electronic Platform for Older Patients With Cancer (eGAP - Electronic Geriatric Assessment Platform)
NCT04824859
A Supportive Care Intervention for Older Caregivers of Older Adults with Advanced Cancer
NCT05244915
Telehealth Education for Asthma Connecting Hospital and Home
NCT04995692
A Patient-centered Communication Tool (UR-GOAL) for Older Patients With Acute Myeloid Leukemia, Their Caregivers, and Their Oncologists
NCT04625413
Evaluating Deep Breathing in Health Participants Using a Device Called Impulse Oscillometry
NCT05085795
The Association Between Loneliness and Substance Use
NCT04938492
Graphic Messages to Prevent E-Cigarette Use Among Black and Latino Adolescents
NCT04899999
Serologic Response to the SARS-CoV-2 (COVID-19) MRNA-1273 Vaccine in Select Subsets of Oncology Patients
NCT04854980
Development of a Personalized Discussion Prioritization Tool for Older Adults Considering Adjuvant Chemotherapy for Breast Cancer
NCT05073432
Use of Dapagliflozin to Reduce Burden of Atrial Fibrillation in Patients Undergoing Catheter Ablation of Symptomatic Atrial Fibrillation
NCT04792190
A Pilot Trial of the Reach Out, Stay Strong, Essentials for Mothers of Newborns (ROSE) Postpartum Depression Prevention Intervention in Pregnant Patients Admitted to Strong Hospital
NCT05225025
Connect for Caregivers
NCT04919070
Wireless TENS for Peripheral Edema (Lower Limb Swelling)
NCT04680533
Effects of Nystatin Suspension Oral Application on Oral Microbial Community
NCT04550546
SP TLF Versus Ho:YAG Laser
NCT05048706
Testing for COVID-19 in High Risk Children With Intellectual and Developmental Disabilities (COV-IDD)
NCT04887129
Reducing Frailty for Older Cancer Survivors Using Supplements
NCT04553666
Memory and Attention Adaptation Training-Geriatrics (MAAT-G) Phase II
NCT04669301
Study About Treatment After a Suicide Attempt
NCT03894462
A Telehealth Advance Care Planning Intervention for Older Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
NCT04745676
CAPABLE Transitions: A Home Health-Based Intervention for the Hospital or Post-Acute Care Facility-to-Home Transition
NCT04460742
PROMIS and Patient Satisfaction
NCT04654910
Radiofrequency (RF) Ablation for Atrial Fibrillation (AF) in Patients With Heart Failure With Preserved Ejection Fraction
NCT04327596
Engage Coaching for Latinos
NCT04875065
Mindfulness to Reduce Loneliness in Older Caregivers
NCT04560088
Osteopathic Manipulative Medicine to Reduce Developmental Delays
NCT04652063
Nerve Stimulation Using a TENS to Provide Pain Relief During Surgery for Overactive Bladder
NCT05330117
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 66 |
| Phase 2 | 81 |
| Phase 3 | 20 |
| Phase 4 | 34 |
Therapeutic Areas
What is open in the University of Rochester pipeline
94 recruiting of 636 indexed (15% open); 448 completed (70%).
Phase mix: 54 late (III/IV) vs 147 early (I/II) (early-phase heavy).
Top condition: Cancer (7 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Rochester: open-pipeline peers nationwide
Peers matched on 636 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Rochester sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 636 trials (± recruiting share)
- US Department of Veterans Affairs · 632 trials · 0% recruiting
- University of Southern California · 617 trials · 16% recruiting
- Baylor College of Medicine · 616 trials · 15% recruiting
- University of California, Davis · 657 trials · 19% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Loma Linda University · 15% recruiting · 237 trials
- Dompé Farmaceutici S.p.A · 15% recruiting · 27 trials
- Vanderbilt-Ingram Cancer Center · 15% recruiting · 189 trials
- Brown University · 15% recruiting · 231 trials
Related
What to do with this University of Rochester page
636 registered trials is a research-attention snapshot, not an endorsement of University of Rochester or any single study.
- 94 of University of Rochester's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Cancer is the condition University of Rochester studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Rochester pipeline card: 636 registered trials from official public datasets.Report a data error.